Pharmaceutical companies are capitalising on the advent of the internet and the development of new media forms to promote their products. electronic detailing, interactive websites, email prompts and viral marketing campaigns using social networking sites such as youTube, mySpace and Facebook are among the tools being used. Such campaigns are targeting both health professionals and the general public. The internet is helping to globalise and to change the nature of pharmaceutical marketing, and thus raises some new challenges for regulators.
Introduction
The internet and related technologies have revolutionised many 
electronic detailing
In the context of drug promotion, detailing has traditionally involved face-to-face contact between a visiting sales representative and a health professional. However, drug companies, especially in North America and Europe, are increasingly turning to electronic detailing or e-detailing for help in marketing their products. E-detailing includes diverse strategies, such as videoconferencing, the provision of electronic education modules, and the use of email and related technologies as prompts and to promote two-way communications. It has been used for disease-awareness campaigns, and for 'customer relationship management'.
Presentations to a pharmaceutical marketing conference in Europe suggest that e-detailing is not popular with all doctors. 2 However, it is cheaper than traditional sales representatives and can result in a significant return on investment through increased sales. Some companies are providing financial incentives for doctors to participate in e-detailing, such as honoraria, product samples, practice tools, and patient education resources. 3 In Poland, for example, Sanofi-Aventis lent physicians internet-connected hand-held devices which were loaded with clinical support information, drug indexes, abstracts of clinical studies, information from key opinion leaders, and advertising and educational materials. In exchange, the doctors participated in a clinical trial of a Sanofi-Aventis drug and entered anonymous patient data into the device. The company aimed to build relationships with the doctors, to use the device as an advertising medium, and to gather feedback.
The company also reported that these doctors then prescribed more of its diabetes products. 3 An important aspect of e-detailing is that it enables 'predictive marketing'. This means that companies can be more effective and timely in eliciting feedback from prescribers in order to tailor marketing strategies to their individual preferences and needs. 4 
Corporate blogs and websites
The global reach of the internet means that Australians now have easy access to overseas blogs and websites promoting prescription medicines and other products, and even selling them.
Safety concerns have been raised about the purchase of prescription, non-prescription and complementary medicines over the internet. 5, 6 Companies are also using blogs and websites to develop 
Viral marketing and social networking sites

Consumer opinion leaders
Ordinary people who influence what other consumers believe and buy. Often employed in web-based marketing.
e-detailing
Information technology-supported promotional activities which provide customers, whether health professionals or patients, with information.
Podcasts
Repositories of audio and video materials that can be broadcast over the internet, and downloaded to portable media players.
Web .0
A second generation of internet-based services, such as social networking sites and wikis, that emphasise online collaboration and sharing among users.
Wikis
Websites that can be edited by anyone who has access to them. The best known example is Wikipedia. 
Regulation
The Medicines Australia Code of Conduct attempts to regulate the promotion of prescription medicines on the internet.
However, it is difficult to police the anonymous marketing of drugs on blogs and forums, or to regulate consumers' access to information from countries where pharmaceutical marketing may be less regulated than in Australia.
Conclusion
The ongoing development of internet-related technologies is likely to provide pharmaceutical manufacturers with further opportunities to influence consumer expectations of health care and prescribing practices. It is also providing new opportunities for those concerned with the quality use of medicines and evidence-based education. 10 Much can be gained from constructive engagement with the world wide web, and 21st century doctors also need to understand its use as a marketing tool.
